| Liposomes of quantum dots configured for passive and active delivery to tumor tissue G Aizik, N Waiskopf, M Agbaria, M Ben-David-Naim, Y Levi-Kalisman, ... Nano Letters 19 (9), 5844-5852, 2019 | 47 | 2019 |
| Delivery of Liposomal Quantum Dots via Monocytes for Imaging of Inflamed Tissue G Aizik, N Waiskopf, M Agbaria, Y Levi-Kalisman, U Banin, G Golomb ACS nano 11 (3), 3038-3051, 2017 | 47 | 2017 |
| Targeting and imaging of monocyte-derived macrophages in rat's injured artery following local delivery of liposomal quantum dots G Aizik, N Waiskopf, M Agbaria, M Ben-David-Naim, MM Nordling-David, ... Journal of controlled release 318, 145-157, 2020 | 15 | 2020 |
| Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity S Biswas, LN Rust, JM Wettengel, S Yusova, M Fischer, JN Carson, ... Nature communications 13 (1), 2995, 2022 | 12 | 2022 |
| Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes S Hirsch, L Hinden, MBD Naim, S Baraghithy, A Permyakova, S Azar, ... Journal of Controlled Release 353, 254-269, 2023 | 7 | 2023 |
| Liposomal siRNA formulations for the treatment of herpes simplex virus-1: in vitro characterization of physicochemical properties and activity, and in vivo biodistribution and … D Jbara-Agbaria, S Blondzik, A Burger-Kentischer, M Agbaria, ... Pharmaceutics 14 (3), 633, 2022 | 7 | 2022 |
| Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer M Agbaria, D Jbara-Agbaria, E Grad, M Ben-David-Naim, G Aizik, ... Journal of Controlled Release 355, 312-326, 2023 | 4 | 2023 |
| Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system P Reus, H Guthmann, N Uhlig, M Agbaria, L Issmail, V Eberlein, ... Journal of Controlled Release 364, 654-671, 2023 | 1 | 2023 |
